{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:47:15Z","timestamp":1781768835276,"version":"3.54.5"},"reference-count":21,"publisher":"American Psychiatric Association Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1176\/appi.ajp.157.9.1461","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:21:35Z","timestamp":1034360495000},"page":"1461-1466","source":"Crossref","is-referenced-by-count":72,"title":["Differentiating Primary From Secondary Negative Symptoms in Schizophrenia: A Study of Neuroleptic-Naive Patients Before and After Treatment"],"prefix":"10.1176","volume":"157","author":[{"given":"Victor","family":"Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Martinez-Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1579BABBDFED","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Heinrichs DW, Wagman AMI: Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145:578\u2013583","DOI":"10.1176\/ajp.145.5.578"},{"key":"R1579BABJFCJC","doi-asserted-by":"crossref","unstructured":"Miller DD, Flaum M, Arndt S, Fleming F, Andreasen NC: Effect of antipsychotic withdrawal on negative symptoms in schizophrenia. Neuropsychopharmacology 1994; 11:11\u201320","DOI":"10.1038\/npp.1994.31"},{"key":"R1579BABDIFFB","doi-asserted-by":"crossref","unstructured":"Flaum M, Andreasen NC: The reliability of distinguishing primary versus secondary negative symptoms. Compr Psychiatry 1995; 36:421\u2013427","DOI":"10.1016\/S0010-440X(95)90249-X"},{"key":"R1579BABJJCFC","doi-asserted-by":"crossref","unstructured":"Peralta V, Cuesta MJ: Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 1999; 40:245\u2013253","DOI":"10.1016\/S0920-9964(99)00047-X"},{"key":"R1579BABGGDIG","doi-asserted-by":"crossref","unstructured":"Breier A, Wolkowitz OM, Doran AR, Roy A, Boronow J, Hommer DW, Pickar D: Neuroleptic responsivity of negative and positive symptoms in schizophrenia. Am J Psychiatry 1987; 144:1549\u20131555","DOI":"10.1176\/ajp.144.12.1549"},{"key":"R1579BABIBEEH","doi-asserted-by":"crossref","unstructured":"Kelley ME, van Kammen DP, Allen DN: Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am J Psychiatry 1999; 156:406\u2013411","DOI":"10.1176\/ajp.156.3.406"},{"key":"R1579BABIEACB","doi-asserted-by":"crossref","unstructured":"Caligiuri MP, Lohr JB, Jeste DV: Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry 1993; 150:1343\u20131348","DOI":"10.1176\/ajp.150.9.1343"},{"key":"R1579BABEIEDG","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane JM, Alvir J, Lieberman JA: Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 1995; 152:1724\u20131729","DOI":"10.1176\/ajp.152.12.1724"},{"key":"R1579BABIIEJA","unstructured":"Kopala LC, Good KP, Fredrikson D, Whitehorn D, Lazier L, Honer WG: Risperidone in first-episode schizophrenia: improvement in symptoms and extrapyramidal signs. Int J Psychiatr Clin Practice 1998; 2:19\u201325"},{"key":"R1579BABHGAAE","doi-asserted-by":"crossref","unstructured":"Andreasen NC, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49:615\u2013623","DOI":"10.1001\/archpsyc.1992.01820080023004"},{"key":"R1579BABDIHCJ","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW: Continuous versus targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry 1990; 147:1138\u20131148","DOI":"10.1176\/ajp.147.9.1138"},{"key":"R1579BABFAICF","doi-asserted-by":"crossref","unstructured":"Addington D, Addington J, Maticka-Tyndale E: Reliability and validity of a depression rating scale for schizophrenia. Schizophr Res 1992; 6:201\u2013208","DOI":"10.1016\/0920-9964(92)90003-N"},{"key":"R1579BABJHHCI","doi-asserted-by":"crossref","unstructured":"Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11\u201319","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"R1579BABJCGBI","doi-asserted-by":"crossref","unstructured":"Prosser ES, Csernansky JG, Kaplan J, Thieman S, Becker TJ, Hollister LE: Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. J Nerv Ment Dis 1987; 175:100\u2013105","DOI":"10.1097\/00005053-198702000-00006"},{"key":"R1579BABDAGCD","doi-asserted-by":"crossref","unstructured":"Carpenter WT, Heinrichs DW, Alphs LD: Treatment of negative symptoms. Schizophr Bull 1985; 11:440\u2013452","DOI":"10.1093\/schbul\/11.3.440"},{"key":"R1579BABFFAAF","doi-asserted-by":"crossref","unstructured":"Tandon R, Ribeiro SCM, DeQuardo JR, Goldman RS, Goodson JA, Greden JF: Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: a replication. Biol Psychiatry 1993; 34:495\u2013497","DOI":"10.1016\/0006-3223(93)90242-6"},{"key":"R1579BABGGEBG","doi-asserted-by":"crossref","unstructured":"Czobor P, Volavka J: Positive and negative symptoms: is their change related? Schizophr Bull 1996; 22:577\u2013590","DOI":"10.1093\/schbul\/22.4.577"},{"key":"R1579BABEIHGA","unstructured":"Serban G, Siegel S, Gaffney M: Response of negative symptoms of schizophrenia to neuroleptic treatment. J Clin Psychiatry 1992; 53:229\u2013234"},{"key":"R1579BABJFJBC","doi-asserted-by":"crossref","unstructured":"Addington D, Addington J, Maticka-Tyndale E: Specificity of the Calgary Depression Scale for schizophrenics. Schizophr Res 1994; 11:239\u2013244","DOI":"10.1016\/0920-9964(94)90017-5"},{"key":"R1579BABFDEHB","doi-asserted-by":"crossref","unstructured":"Leucht S, Pitschel-Walz G, Kissling AD: Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trials. Schizophr Res 1999; 35:51\u201368","DOI":"10.1016\/S0920-9964(98)00105-4"},{"key":"R1579BABHDGCG","doi-asserted-by":"crossref","unstructured":"Rifkin A, Quitkin F, Klein DF: Akinesia. Arch Gen Psychiatry 1975; 32:672\u2013674","DOI":"10.1001\/archpsyc.1975.01760230138011"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.157.9.1461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T10:22:00Z","timestamp":1722421320000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.157.9.1461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["10.1176\/appi.ajp.157.9.1461"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.157.9.1461","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,1]]}}}